Literature DB >> 10629885

[Actin depolymerizing action by marine toxin, pectenotoxin-2].

M Hori1, Y Matsuura, R Yoshimoto, H Ozaki, T Yasumoto, H Karaki.   

Abstract

Pectenotoxin-2 (PCTX-2), which is one of Diarrhetic Shellfish Poisoning (DSP), is a family of cyclic polyether macrolide toxin isolated from scallop Patinopecten yessoensis. Although PCTX-2 has a potent cytotoxic activities against several cancer cell lines, the biochemical activity of PCTX-2 has not been determined yet. To clarify the biochemical activity of PCTX-2 is the aime in this study. PCTX-2 inhibited the contractions elicited by 72.7 mM KCl or 1 microM phenyrephrine in a concentration dependent manner in the isolated rat aorta. In A10 cells, actin stressfiber in center but not in periphery of the cell was disrupted by PCTX-2 without any visible shape change. By monitoring fluorescent intensity of pyrenyl-actin, PCTX-2 was found to inhibit the velocity and the degree of actin polymerization in a concentration dependent manner. In addition, PCTX-2 decreased viscosity of F-actin measured with falling ball viscometry. Stoichiometric analysis indicated that PCTX-2 forms 1:4 complex with G-actin. These results suggest that PCTX-2 is a potent natural actin depolymerizing compound with unique mode of action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629885     DOI: 10.1254/fpj.114.supplement_225

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


  3 in total

1.  A structural basis for regulation of actin polymerization by pectenotoxins.

Authors:  John S Allingham; Christopher O Miles; Ivan Rayment
Journal:  J Mol Biol       Date:  2007-05-25       Impact factor: 5.469

2.  Cytoskeletal toxicity of pectenotoxins in hepatic cells.

Authors:  B Espiña; M C Louzao; I R Ares; E Cagide; M R Vieytes; F V Vega; J A Rubiolo; C O Miles; T Suzuki; T Yasumoto; L M Botana
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

Review 3.  Pectenotoxin-2 from marine sponges: a potential anti-cancer agent-a review.

Authors:  Gi-Young Kim; Wun-Jae Kim; Yung Hyun Choi
Journal:  Mar Drugs       Date:  2011-11-02       Impact factor: 6.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.